Showing results (191-200 of 219) with videos related to
Sort By:
Pageof 22
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2005
Evidence for a functional role of the second C5a receptor C5L2Hongwei Gao, Thomas A Neff, Ren-Feng Guo, et al.Antioxidants & Redox Signaling|February 9, 2008
Ability of antioxidant liposomes to prevent acute and progressive pulmonary injuryLaszlo M Hoesel, Michael A Flierl, Andreas D Niederbichler, et al.Experimental Dermatology|September 12, 2007
Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophilsVictoria M Shpacovitch, Stephan Seeliger, Markus Huber-Lang, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 5, 2003
Neutrophil C5a receptor and the outcome in a rat model of sepsisRen-Feng Guo, Niels C Riedemann, Kurt D Bernacki, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 27, 2008
Adverse functions of IL-17A in experimental sepsisMichael A Flierl, Daniel Rittirsch, Hongwei Gao, et al.Plos Pathogens|June 9, 2009
Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathwaysDaniel Rittirsch, Michael A Flierl, Danielle E Day, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2016
Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In VitroMiriam Kalbitz, Fatemeh Fattahi, Todd J Herron, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Structure-function relationships of human C5a and C5aRMarkus S Huber-Lang, J Vidya Sarma, Stephanie R McGuire, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Stat3 activation in acute lung injuryHongwei Gao, Ren-Feng Guo, Cecilia L Speyer, et al.Intensive Care Medicine|October 3, 2019
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumabRichard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.Pageof 22